Author name: Yvanka Gilliam

Hepatitis B and C- Differences in Diagnosis and Treatment

AUTHOR(S) Gilliam Y1, Singh SS1, Chen Y1, Kim J2, Fang H3 1Kantar, Singapore, Singapore, 2Kantar, Seoul, South Korea, 3Kantar Taiwan, Taipei, Taiwan OBJECTIVES Viral hepatitis B and C are considered serious public health issues that affect 325 million people globally and has led to approximately 1.34 million deaths annually worldwide. Most of these deaths are […]

Hepatitis B and C- Differences in Diagnosis and Treatment Read More »

Vaccination Rates Among the General Adult Population and High-Risk Groups in EU, US, JAPAN, South Korea and Taiwan

AUTHOR(S) Gilliam Y1, Teoh C2, Singh SS2, Chen Y2, Grillo V2 1Kantar, Douglasville, Singapore, 2Kantar, Singapore, Singapore OBJECTIVES : One of the targets of the Global Vaccine Action plan, is to provide equitable access to vaccines to all people. It is, therefore, important to assess the vaccination rates among both general adult population and the

Vaccination Rates Among the General Adult Population and High-Risk Groups in EU, US, JAPAN, South Korea and Taiwan Read More »

Comparison of Quality of Life and Burden of Lower Back Pain Among Patients with and without a Diagnosis in Korea, Taiwan, JAPAN and USA

AUTHOR(S) Chen Y1, Singh SS2, Fang H3, Jung S4, Gilliam Y5, Grillo V1 1Kantar, Singapore, Singapore, 2Kantar Health, Singapore, Singapore, 3Kantar Taiwan, Taipei, Taiwan, 4Kantar, Seoul, South Korea, 5Kantar, Douglasville, Singapore OBJECTIVES : To explore the differences in health-related quality of life (HRQoL), work productivity and activity impairment (WPAI), and healthcare resource utilization (HRU) among

Comparison of Quality of Life and Burden of Lower Back Pain Among Patients with and without a Diagnosis in Korea, Taiwan, JAPAN and USA Read More »

Rates of COPD Diagnosis and Health Outcomes in at Risk Populations – An Insight to the Diagnosis of COPD

AUTHOR(S) Chen Y1, Gilliam Y2, Singh SS1, Jung S3, Fang H4 1Kantar, Singapore, Singapore, 2Kantar, Douglasville, Singapore, 3Kantar, Seoul, South Korea, 4Kantar Taiwan, Taipei, Taiwan OBJECTIVES : Chronic obstructive pulmonary disease (COPD) is a global health concern and is a major cause of chronic morbidity and mortality worldwide. However, identifying patients has proved challenging, resulting

Rates of COPD Diagnosis and Health Outcomes in at Risk Populations – An Insight to the Diagnosis of COPD Read More »

The Challenges and Unmet Needs in the Management of Hepatocellular Carcinoma (HCC)

AUTHOR(S) Yen C1, Ramaswamy B1, Baladi JF1, Acorda A2, Xu K2, Gilliam Y2, Gowindah R2, Singh SS2, Chen Y2 1Ipsen, Singapore, Singapore, 2Kantar, Singapore, Singapore OBJECTIVES: HCC is the 6th most common cancer and 4th leading cause of cancer deaths in the world, with more than 70% of cases diagnosed in Asia. METHODS: Primary research was conducted amongst key

The Challenges and Unmet Needs in the Management of Hepatocellular Carcinoma (HCC) Read More »

Uncovering the Hidden Burden of Depression – A Country Comparison

AUTHOR(S) Ken-Opurum J1, Fukuda T2, Chen Y3, Gilliam Y3, Stankus A41Kantar, Brooklyn, NY, USA, 2National Institute of Public Health, Wako-shi, 11, Japan,3Kantar, Singapore, Singapore, 4Kantar, New York, NY, USA PRESENTATION DOCUMENTS PMH14 Uncovering the Hidden Burden of Depression A Country Comparison.pdf OBJECTIVES: An estimated 264 million individuals suffer from depression globally. However, there may be

Uncovering the Hidden Burden of Depression – A Country Comparison Read More »

Patterns in patients with hepatocellular carcinoma (HCC)

Differences and similarities in presentation and management patterns in patients with hepatocellular carcinoma (HCC) across Hong Kong, Singapore and Thailand. Abstract 166P Background An estimated 841,000 new Hepatocellular Carcinoma (HCC) cases have been identified globally, with Asia having the highest incidence (73%). However, there is limited real world data on how HCC is diagnosed and

Patterns in patients with hepatocellular carcinoma (HCC) Read More »

ASCO GI PUBLICATION 2019_JCO

Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC): Data from HCC registry in Asia. Pierce K. H. Chow, Lequn Li, Jiangtao Li, Fan Jia, Hee-Jee Wang, Kiyoshi Hasegawa, Jin-Mo Yang, Poh-Seng Tan, Shukui Qin, Kwang-Hyub Han, Brian Goh, Ho Seong Han, Junji Furuse, Xu Zhu, Joanna Zhi Jie Ling, Mihir Gandhi Background: HCC is the 6th most common cancer worldwide with > 70% of cases in Asia.

ASCO GI PUBLICATION 2019_JCO Read More »

ASCO PUBLICATION 2018_JCO

Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC) between China and Singapore: Initial data from the HCC Registry in Asia. Pierce K. H. Chow, Lequn Li, Jiangtao Li, Poh-Seng Tan, Fan Jia, Shukui Qin, Yvanka Marie Gilliam, Joanna Zhi Jie Ling, Mihir Gandhi Background: HCC is the 6th most common cancer in the world with > 70% of cases in

ASCO PUBLICATION 2018_JCO Read More »

ISPOR ABSTRACT 2020

APAC Overview of the Accelerated Approval Pathways- Applications in LUNG Cancer Johnson I1, Chou B1, Grillo V2, Sevilla M2, Singh SS2, Gilliam Y21Amgen, JAPAC, Hong Kong, Hong Kong, 2Kantar, Singapore, Singapore OBJECTIVES: Speeding up the delivery of drugs that treat serious diseases helps ensure timely access to important therapeutic interventions. The aim of this review is to provide

ISPOR ABSTRACT 2020 Read More »

Scroll to Top
Scroll to Top